DERMATOLOGY DIAGNOSTIC DEVICES AND THERAPEUTICS MARKET ANALYSIS
New product launches/approvals
Innovation of new and improved products in the market is expected to keep the market more competitive to combat with the latest product. For example, the new product Dupixent approved by the U.S. FDA in 2017, is an injectable medication for adult patients with moderate or acute eczema. This is mainly for patients affected by the disease which cannot be controlled with prescription therapies used on skin (topically).
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
